Migdal Insurance & Financial Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,830	Closed	-$515K	–	747
2020 Q3	$515K	Buy	1,830 +947	+107%	+$223K	0.01%	362
2020 Q2	$167K	Buy	883 +193	+28%	+$31.4K	﹤0.01%	363
2020 Q1	$85K	Buy	690 +326	+90%	+$51K	﹤0.01%	410
2019 Q4	$60K	Buy	364 +193	+113%	+$32.1K	﹤0.01%	618
2019 Q3	$21K	Buy	171 +10	+6%	+$1.33K	﹤0.01%	646
2019 Q2	$20K	Buy	161 +91	+130%	+$11.6K	﹤0.01%	687
2019 Q1	$9K	Buy	70 +47	+204%	+$6.34K	﹤0.01%	677
2018 Q4	$3K	Buy	+23	New	+$3.05K	﹤0.01%	688

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ONC Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 1,830 shares — an estimated $515K sold.

Migdal Insurance & Financial Holdings first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $515K in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

Migdal Insurance & Financial Holdings reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 1,830 BeOne Medicines Ltd shares in Q4 2020, an estimated $515K.
Migdal Insurance & Financial Holdings first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
Migdal Insurance & Financial Holdings's BeOne Medicines Ltd position peaked at $515K in Q3 2020.
248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.